VIM
PRCT icon

VELA Investment Management’s Procept Biorobotics PRCT Stock Holding History

VELA Investment Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.83M Buy
73,039
+34,801
+91% +$981K 0.42% 77
2025
Q4 		$1.2M Buy
+38,238
New +$1.27M 0.28% 106
2024
Q4 		– Sell
-19,616
Closed -$1.57M – 171
2024
Q3 		$1.57M Sell
19,616
-871
-4% -$61.9K 0.48% 75
2024
Q2 		$1.25M Hold
20,487
– – 0.39% 92
2024
Q1 		$1.01M Hold
20,487
– – 0.34% 98
2023
Q4 		$859K Buy
20,487
+2,757
+16% +$93.9K 0.33% 102
2023
Q3 		$582K Buy
+17,730
New +$604K 0.26% 102

Other funds holding PRCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VELA Investment Management's PRCT Position: Q1 2026 in Review

VELA Investment Management increased its Procept Biorobotics (PRCT) stake by 91% in Q1 2026, buying an estimated $981K and bringing the position to 73,039 shares worth $1.83M. The position accounts for 0.42% of the portfolio, ranked #77.

VELA Investment Management first reported a position in PRCT in Q3 2023 and has held it in 7 quarters since. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • VELA Investment Management held 73,039 shares of Procept Biorobotics worth $1.83M as of Q1 2026.
  • VELA Investment Management bought 34,801 Procept Biorobotics shares in Q1 2026, an estimated $981K.
  • Procept Biorobotics made up 0.42% of VELA Investment Management's portfolio in Q1 2026, its #77 holding.
  • VELA Investment Management first reported a position in Procept Biorobotics in Q3 2023 and has held it in 7 quarters since.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on VELA Investment Management's 13F filing for Q1 2026, filed 8 May 2026.